75 related articles for article (PubMed ID: 9422066)
1. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer].
Katsumata K; Yamamoto K; Shibata K; Murano A; Kawasaki M; Moriwaki R; Nagakawa Y; Ogata T; Koyanagi Y; Kusama M
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2227-32. PubMed ID: 9422066
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Momose F
Gan To Kagaku Ryoho; 1995 Jan; 22(1):83-6. PubMed ID: 7826082
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer.
Katsumata K; Tomioka H; Kusama M; Aoki T; Koyanagi Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):86-8. PubMed ID: 12764670
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
Matsuoka T; Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Tsuchiya A; Takenoshita S
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1051-5. PubMed ID: 10925694
[TBL] [Abstract][Full Text] [Related]
5. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
Ito Y; Hoshino A; Ohara K; Kamiya O; Nagata K; Kojima T; Kinoshita T; Sugiura I
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer].
Inoue K; Tabei T; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 1999 Apr; 26(5):637-42. PubMed ID: 10234294
[TBL] [Abstract][Full Text] [Related]
7. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of mitoxantrone, doxifluridine and medroxyprogesterone acetate as second-line treatment for anthracycline-resistant metastatic breast cancer.
Yokoe T; Iino Y; Sugamata N; Aoyagi H; Takai Y; Takei H; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1995; 15(5B):2303-5. PubMed ID: 8572643
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
Okamoto Y; Tominaga T; Okuyama N; Sawada T; Kou Y
Gan To Kagaku Ryoho; 2003 May; 30(5):661-7. PubMed ID: 12795098
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.
Misset JL; Metz R; Gil-Delgado M; Keiling R; Cappelaere P; Armand JP; Prévot G; Grimbert J; Mathé G; Hibberd M
Anticancer Res; 1987; 7(4B):737-40. PubMed ID: 3674760
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.
Nishimura R; Tominaga T; Kimura M; Yanagita Y; Tamaki N; Asaishi K; Okamoto Y; Okuyama N; Takeuchi H; Inaba M; Doi T
Anticancer Drugs; 2008 Oct; 19(9):911-5. PubMed ID: 18766005
[TBL] [Abstract][Full Text] [Related]
14. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.
Nishimura R; Tominaga T; Mitsuyama S; Aoyama H; Asaga T; Ohno S; Okuyama N; Kimura M; Iwase H; Kanda K; Koga T; Shiba E; Ikeda T
Anticancer Res; 2004; 24(3b):2085-91. PubMed ID: 15274405
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast.
Leonard RC; Cornbleet MA; Kaye SB; Soukop M; White G; Hutcheon AW; Robinson S; Kerr ME; Smyth JF
J Clin Oncol; 1987 Jul; 5(7):1056-63. PubMed ID: 3298559
[TBL] [Abstract][Full Text] [Related]
17. [A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
Matsuura Y; Nakamura H; Kogure K; Fukazawa M; Okuyama Y; Kawano E; Ishii A; Nishimura M; Hashimoto S; Oh H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):237-41. PubMed ID: 8311495
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
19. [Mitoxantrone-containing combination chemotherapy in patients with non-Hodgkin's lymphoma].
Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3034-9. PubMed ID: 3532959
[TBL] [Abstract][Full Text] [Related]
20. Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.
Tolcher AW; Gelmon KA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):28-32. PubMed ID: 7638639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
